Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2440]

CHMP positive opinion on apalutamide for patients with non-metastatic castration-resistant prostate cancer

CHMP positive opinion on apalutamide for patients with non-metastatic castration-resistant prostate cancer

Surgery & combination therapy optimises results in aggressive prostate cancer management

Surgery & combination therapy optimises results in aggressive prostate cancer management

Patients with cancers of the gullet, stomach and bowel respond well to new anti-HER2 drug

Patients with cancers of the gullet, stomach and bowel respond well to new anti-HER2 drug

First blood based biomarker in response to the treatment of the most aggressive prostate cancer

First blood based biomarker in response to the treatment of the most aggressive prostate cancer

Drug designed to boost radiotherapy for hard to treat cancers taken safely by patients

Drug designed to boost radiotherapy for hard to treat cancers taken safely by patients

Scientists identify potential new treatment strategy for kidney cancer

Scientists identify potential new treatment strategy for kidney cancer

Prostate cancer radiotherapy more precisely targeted with nuclear medicine imaging

Prostate cancer radiotherapy more precisely targeted with nuclear medicine imaging

Researchers have unlocked secrets about engineered protein receptor CAR

Researchers have unlocked secrets about engineered protein receptor CAR

Antihormone therapy linked with higher heart failure risk in prostate cancer patients

Antihormone therapy linked with higher heart failure risk in prostate cancer patients

Brain-derived compounds show surprising and beneficial results for cancer in lab studies

Brain-derived compounds show surprising and beneficial results for cancer in lab studies

More from ecancer